Medpace Holdings Inc
MEDP
NASDAQ. Currency in USD
201.14 -4.86 ( -2.36% )
Market Cap.
6.26B
Beta (5Y monthly)
1.45
Price/Earnings
32.19
EPS (TTM)
6.52
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
269,162
1y Target Est.
218.33
Day's Range
52 Week's Range
Historical Summary
Performance
1 Month
-8.86%
YTD
-7.58%
1Y
-6.39%
2Y
43.55%
19.83% ann.
3Y
141.18%
34.10% ann.
5Y
425.03%
39.33% ann.
EPS growth
1Y
32.79%
2Y
88.44%
37.31% ann.
3Y
123.29%
30.70% ann.
5Y
343.54%
34.71% ann.
Share Buybacks
3 Months
4.28%
6 Months
11.31%
1Y
14.04%
2Y
14.59%
3Y
14.75%
5Y
17.99%
About Medpace Holdings Inc
Sector
Healthcare
Industry
Diagnostics & Research
Website
https://www.medpace.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
35.94M
Employees
5000
Address
5375 Medpace Way, Cincinnati, OH, United States, 45227
Latest news

Ensign Group (ENSG) Unveils Dividend Hike to Reward Shareholders
Ensign Group's (ENSG) latest dividend hike reflects strong financial standing and intensified focus in the...
By Zacks Investment Research - 5 weeks ago

Zacks Industry Outlook Highlights Medpace, HealthEquity and Progyny
Medpace, HealthEquity and Progyny have been highlighted in this Industry Outlook article.
By Zacks Investment Research - 6 weeks ago

HCA Healthcare's (HCA) ESR Program Aids Post-Surgery Recovery
HCA Healthcare's (HCA) ESR program remains on track to attract more patients to choose HCA's...
By Zacks Investment Research - 6 weeks ago

3 Medical Services Stocks to Buy Amid Industry Challenges
The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, HQY and...
By Zacks Investment Research - 6 weeks ago

Here's Why Investors Should Retain LabCorp (LH) Stock for Now
Investors are optimistic about LabCorp (LH), led by strength in its Drug Development business.
By Zacks Investment Research - 7 weeks ago

HealthEquity (HQY) Stock Falls 1.6% Despite Q3 Earnings Beat
HealthEquity (HQY) witnesses solid growth in HSAs besides recording robust performances in all its segments...
By Zacks Investment Research - 7 weeks ago

Quest Diagnostics' (DGX) New Deal to Extend Laboratory Access
Quest Diagnostics' (DGX) new collaboration with Northern Light Health will enhance access to diagnostics services...
By Zacks Investment Research - 7 weeks ago

Quest Diagnostics (DGX) Volume Growth Aids, Margin Woes Stay
Quest Diagnostics' (DGX) legacy base business is growing amid softer utilization trends.
By Zacks Investment Research - 7 weeks ago